CRISPR‐Cas9‐modified <i>pfmdr1</i> protects <i>Plasmodium falciparum</i> asexual blood stages and gametocytes against a class of piperazine‐containing compounds but potentiates artemisinin‐based combination therapy partner drugs
2016 · Molecular Microbiology · 67 citations
https://doi.org/10.1111/mmi.13397